Cargando…
Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project
PURPOSE: Quality of life (QoL) plays an important role in recovery—especially after an incisive diagnosis such as breast cancer. Here, we present a comprehensive assessment of QoL for pre- and postmenopausal patients, starting from initial systemic treatment of early breast cancer until 3 years late...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534521/ https://www.ncbi.nlm.nih.gov/pubmed/30868393 http://dx.doi.org/10.1007/s10549-019-05197-w |
_version_ | 1783421421703135232 |
---|---|
author | Marschner, Norbert Trarbach, Tanja Rauh, Jacqueline Meyer, Dirk Müller-Hagen, Sigrun Harde, Johanna Dille, Stephanie Kruggel, Lisa Jänicke, Martina |
author_facet | Marschner, Norbert Trarbach, Tanja Rauh, Jacqueline Meyer, Dirk Müller-Hagen, Sigrun Harde, Johanna Dille, Stephanie Kruggel, Lisa Jänicke, Martina |
author_sort | Marschner, Norbert |
collection | PubMed |
description | PURPOSE: Quality of life (QoL) plays an important role in recovery—especially after an incisive diagnosis such as breast cancer. Here, we present a comprehensive assessment of QoL for pre- and postmenopausal patients, starting from initial systemic treatment of early breast cancer until 3 years later, in patients from a so-called “real-world” setting. METHODS: 251 premenopausal and 478 postmenopausal patients with early breast cancer have been recruited into the longitudinal MaLife project within the prospective, multicentre, German Tumour Registry Breast Cancer between 2011 and 2015. The questionnaires FACT-G, FACT-Taxane, FACT-ES, EORTC QLQ-BR23, BFI and HADS were filled in at start of treatment (T0), 6, 12, 24 and 36 months later. The proportion of patients with clinically meaningful changes at 36 months was determined. RESULTS: This first interim analysis shows that the FACT-G global QoL improved over time regardless of the menopausal status. However, clinically meaningful decrease of social/family well-being (48–51%), arm symptoms (44–49%) and symptoms of neurotoxicity (55–56%) was frequently reported 3 years after start of treatment. Many premenopausal patients also reported a clinically meaningful worsening of endocrine symptoms (64%), emotional well-being (36%) and fatigue intensity (37%). Additionally, 3 years after start of treatment, 15% of the patients were classified as doubtful cases and 18% as definite cases of anxiety. CONCLUSIONS: Despite improvements in global QoL, breast cancer survivors report worsened ailments 3 years after start of therapy. Follow-up care should distinguish between premenopausal patients needing special attention for emotional/menopausal issues, and postmenopausal patients needing particular care regarding physical concerns. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10549-019-05197-whttps://doi.org/10.1007/s10549-019-05197-w) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6534521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-65345212019-06-07 Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project Marschner, Norbert Trarbach, Tanja Rauh, Jacqueline Meyer, Dirk Müller-Hagen, Sigrun Harde, Johanna Dille, Stephanie Kruggel, Lisa Jänicke, Martina Breast Cancer Res Treat Epidemiology PURPOSE: Quality of life (QoL) plays an important role in recovery—especially after an incisive diagnosis such as breast cancer. Here, we present a comprehensive assessment of QoL for pre- and postmenopausal patients, starting from initial systemic treatment of early breast cancer until 3 years later, in patients from a so-called “real-world” setting. METHODS: 251 premenopausal and 478 postmenopausal patients with early breast cancer have been recruited into the longitudinal MaLife project within the prospective, multicentre, German Tumour Registry Breast Cancer between 2011 and 2015. The questionnaires FACT-G, FACT-Taxane, FACT-ES, EORTC QLQ-BR23, BFI and HADS were filled in at start of treatment (T0), 6, 12, 24 and 36 months later. The proportion of patients with clinically meaningful changes at 36 months was determined. RESULTS: This first interim analysis shows that the FACT-G global QoL improved over time regardless of the menopausal status. However, clinically meaningful decrease of social/family well-being (48–51%), arm symptoms (44–49%) and symptoms of neurotoxicity (55–56%) was frequently reported 3 years after start of treatment. Many premenopausal patients also reported a clinically meaningful worsening of endocrine symptoms (64%), emotional well-being (36%) and fatigue intensity (37%). Additionally, 3 years after start of treatment, 15% of the patients were classified as doubtful cases and 18% as definite cases of anxiety. CONCLUSIONS: Despite improvements in global QoL, breast cancer survivors report worsened ailments 3 years after start of therapy. Follow-up care should distinguish between premenopausal patients needing special attention for emotional/menopausal issues, and postmenopausal patients needing particular care regarding physical concerns. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10549-019-05197-whttps://doi.org/10.1007/s10549-019-05197-w) contains supplementary material, which is available to authorized users. Springer US 2019-03-13 2019 /pmc/articles/PMC6534521/ /pubmed/30868393 http://dx.doi.org/10.1007/s10549-019-05197-w Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Epidemiology Marschner, Norbert Trarbach, Tanja Rauh, Jacqueline Meyer, Dirk Müller-Hagen, Sigrun Harde, Johanna Dille, Stephanie Kruggel, Lisa Jänicke, Martina Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project |
title | Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project |
title_full | Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project |
title_fullStr | Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project |
title_full_unstemmed | Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project |
title_short | Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project |
title_sort | quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective malife project |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534521/ https://www.ncbi.nlm.nih.gov/pubmed/30868393 http://dx.doi.org/10.1007/s10549-019-05197-w |
work_keys_str_mv | AT marschnernorbert qualityoflifeinpreandpostmenopausalpatientswithearlybreastcanceracomprehensiveanalysisfromtheprospectivemalifeproject AT trarbachtanja qualityoflifeinpreandpostmenopausalpatientswithearlybreastcanceracomprehensiveanalysisfromtheprospectivemalifeproject AT rauhjacqueline qualityoflifeinpreandpostmenopausalpatientswithearlybreastcanceracomprehensiveanalysisfromtheprospectivemalifeproject AT meyerdirk qualityoflifeinpreandpostmenopausalpatientswithearlybreastcanceracomprehensiveanalysisfromtheprospectivemalifeproject AT mullerhagensigrun qualityoflifeinpreandpostmenopausalpatientswithearlybreastcanceracomprehensiveanalysisfromtheprospectivemalifeproject AT hardejohanna qualityoflifeinpreandpostmenopausalpatientswithearlybreastcanceracomprehensiveanalysisfromtheprospectivemalifeproject AT dillestephanie qualityoflifeinpreandpostmenopausalpatientswithearlybreastcanceracomprehensiveanalysisfromtheprospectivemalifeproject AT kruggellisa qualityoflifeinpreandpostmenopausalpatientswithearlybreastcanceracomprehensiveanalysisfromtheprospectivemalifeproject AT janickemartina qualityoflifeinpreandpostmenopausalpatientswithearlybreastcanceracomprehensiveanalysisfromtheprospectivemalifeproject AT qualityoflifeinpreandpostmenopausalpatientswithearlybreastcanceracomprehensiveanalysisfromtheprospectivemalifeproject |